Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

Impact of Tiered Co-Pays: A Survey of Patients and Pharmacists

Employers increasingly have adopted strategies to reduce prescription drug expenditures, including cost-sharing arrangements that require employees to pay a greater share of the costs. In 2002, approximately 57% of people with employer-sponsored health benefits were enrolled in multi-tier copay plans. The growing use of tiered benefit plans and increasing co-pay levels has prompted concern that higher co-pays may lead patients, particularly those with chronic illnesses, to reduce their prescription drug compliance and, consequently, experience negative health outcomes that result in increased utilization of other health care services.

Newsletter Volume

E.V.I.dently December 2014

NPC MessageHave a Great Research Idea? We Might Have a Grant for That.When we hear from a wide range of health care stakeholders, it provides us with...
YouTube Videos

Why are quality measures important? We asked health care thought leaders to tell us why.

Quality measurement, tied to financial incentives, is one of many approaches accountable care programs are using to promote system-wide improvement....
Blog Post

Assessing the Value of Drugs for Formulary Decisions

Some of the National Pharmaceutical Council's (NPC) research partners participated today on a panel, "Best Practices for Assessing the Value of Drugs...
Newsletter Volume

E.V.I.dently September 2014

Message From NPCPatient Access to Medicines: A Growing ChallengeFor health care consumers, the rationale for why some medicines are covered by their...
Press Release

Specialty Medications: Shifting the Focus From “How Much” We Spend to “How Well” We Spend

Washington, DC, June 9, 2014—As health care decision-makers grapple with how to ensure access to specialty medications, the University of Michigan...
Press Release

Fellowship in Policy Impact of Comparative Effectiveness Research Awarded By National Pharmaceutical Council and George Washington University

[[{"fid":"25703","view_mode":"teaser","type":"media","link_text":null,"attributes":{"height":"360","width":"240","border":"0","alt":"chuck-shih","...
Press Release

Study Quantifies Impact of Pharmaceuticals on Enhanced Productivity

(WASHINGTON, DC, August 1, 2012)–The costs to employers of chronic health conditions on employee productivity are well documented, but few studies...
Press Release

New Survey Shows Employers Eyeing CER, PCORI for Health Information

Washington, DC, June 22, 2011--Employers are aware of comparative effectiveness research (CER) and its potential to answer critical questions about...
Commentary and Testimony Page

Leveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?

A growing chorus of voices is publicly sharing data on the effectiveness of treatment options, but one viewpoint has long been shut out of key areas...
Commentary and Testimony Page

Framework Helps ACOs Leverage Pharmaceuticals to Realize Quality, Cost Goals

Medications are more than an item on the balance sheet for health care providers. Pharmaceuticals offer a route to manage costs while achieving...
Commentary and Testimony Page

National Pharmaceutical Council Prepared Commentary Before the Patient-Centered Outcomes Research Institute

Thank you for the opportunity to comment. I have enjoyed the opportunity to witness first-hand the progress, careful thought and deliberation, and...
Commentary and Testimony Page

Comparative Effectiveness Research and the Changing Health Care Landscape

This content appeared in the January 2, 2012 print edition of Chain Drug Review. In the span of just one year, the health care landscape has...
YouTube Videos

Why are quality measures important? We asked health care thought leaders to tell us why.

Quality measurement, tied to financial incentives, is one of many approaches accountable care programs are using to promote system-wide improvement....
YouTube Videos

How CEPAC Reviews and Disseminates Health Care Evidence

Institute for Clinical and Economic Review (ICER) President Dr. Steven Pearson describes one of his organization's main initiatives, the New England...
YouTube Videos

Can We Bring Clarity, Consistency and Transparency to Payer Coverage Decisions?

There is a bit of a "black box" around the formulary decision-making process. As a result, decisions about treatment access are often unpredictable...
YouTube Videos

Ensuring Inclusive and Diverse Research

Andre Williams, CEO of the Association of Black Cardiologists explains that research should be inclusive and diverse, taking racial, ethnic and...
Blog Post

Assessing the Value of Drugs for Formulary Decisions

Some of the National Pharmaceutical Council's (NPC) research partners participated today on a panel, "Best Practices for Assessing the Value of Drugs...
Blog Post

#TBT: Senior Citizens Day & Individualized Pharmaceutical Care

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
Blog Post

#TBT: Consumer-Directed Health Plans & Employers’ Decision-Making

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
Blog Post

Will CER Really Deliver Better Patient Outcomes?

With billions of public dollars directed to comparative effectiveness research (CER) through the 2009 stimulus package and the subsequent passage of...

Research

Consumer-Directed Health Plans: Pharmacy Benefits & "Better Practices"

On behalf of the National Pharmaceutical Council, Th

Transparency in Evidence Evaluation and Formulary Decision-Making

Although the type of evidence required to make healt

  •  
  • 1 of 26
  • >